vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and PROG Holdings, Inc. (PRG). Click either name above to swap in a different company.

PROG Holdings, Inc. is the larger business by last-quarter revenue ($651.6M vs $487.7M, roughly 1.3× CLOVER HEALTH INVESTMENTS, CORP.). PROG Holdings, Inc. runs the higher net margin — 5.5% vs -10.1%, a 15.6% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -19.6%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 4.9%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

PROG Holdings, Inc. is a U.S.-based financial technology firm providing flexible lease-to-own and point-of-sale financing solutions to consumers. Operating primarily in the U.S. market, its core segments include retail partner financing, consumer lending, and payment services that help customers access electronics and household goods without traditional credit requirements.

CLOV vs PRG — Head-to-Head

Bigger by revenue
PRG
PRG
1.3× larger
PRG
$651.6M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+64.4% gap
CLOV
44.7%
-19.6%
PRG
Higher net margin
PRG
PRG
15.6% more per $
PRG
5.5%
-10.1%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
4.9%
PRG

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CLOV
CLOV
PRG
PRG
Revenue
$487.7M
$651.6M
Net Profit
$-49.3M
$36.1M
Gross Margin
Operating Margin
-10.1%
10.0%
Net Margin
-10.1%
5.5%
Revenue YoY
44.7%
-19.6%
Net Profit YoY
-123.2%
3.8%
EPS (diluted)
$3.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
PRG
PRG
Q1 26
$651.6M
Q4 25
$487.7M
$525.4M
Q3 25
$496.6M
$595.1M
Q2 25
$477.6M
$604.7M
Q1 25
$462.3M
$684.1M
Q4 24
$337.0M
$558.9M
Q3 24
$331.0M
$606.1M
Q2 24
$356.3M
$592.2M
Net Profit
CLOV
CLOV
PRG
PRG
Q1 26
$36.1M
Q4 25
$-49.3M
$40.5M
Q3 25
$-24.4M
$33.1M
Q2 25
$-10.6M
$38.5M
Q1 25
$-1.3M
$34.7M
Q4 24
$-22.1M
$57.5M
Q3 24
$-9.2M
$84.0M
Q2 24
$7.4M
$33.8M
Gross Margin
CLOV
CLOV
PRG
PRG
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
CLOV
CLOV
PRG
PRG
Q1 26
10.0%
Q4 25
-10.1%
6.9%
Q3 25
-4.9%
9.0%
Q2 25
-2.2%
10.0%
Q1 25
-0.3%
8.2%
Q4 24
-6.4%
8.9%
Q3 24
-2.7%
8.1%
Q2 24
2.0%
9.4%
Net Margin
CLOV
CLOV
PRG
PRG
Q1 26
5.5%
Q4 25
-10.1%
7.7%
Q3 25
-4.9%
5.6%
Q2 25
-2.2%
6.4%
Q1 25
-0.3%
5.1%
Q4 24
-6.6%
10.3%
Q3 24
-2.8%
13.9%
Q2 24
2.1%
5.7%
EPS (diluted)
CLOV
CLOV
PRG
PRG
Q1 26
$3.68
Q4 25
$0.99
Q3 25
$0.82
Q2 25
$0.95
Q1 25
$0.83
Q4 24
$1.33
Q3 24
$1.94
Q2 24
$0.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
PRG
PRG
Cash + ST InvestmentsLiquidity on hand
$78.3M
$69.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$774.4M
Total Assets
$541.0M
$2.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
PRG
PRG
Q1 26
$69.4M
Q4 25
$78.3M
$308.8M
Q3 25
$292.6M
Q2 25
$222.0M
Q1 25
$213.3M
Q4 24
$194.5M
$90.9M
Q3 24
$288.0M
$221.7M
Q2 24
$254.8M
$250.1M
Total Debt
CLOV
CLOV
PRG
PRG
Q1 26
Q4 25
$594.9M
Q3 25
Q2 25
Q1 25
Q4 24
$643.6M
Q3 24
Q2 24
Stockholders' Equity
CLOV
CLOV
PRG
PRG
Q1 26
$774.4M
Q4 25
$308.7M
$746.4M
Q3 25
$340.9M
$703.6M
Q2 25
$344.2M
$668.7M
Q1 25
$336.1M
$654.4M
Q4 24
$341.1M
$650.3M
Q3 24
$342.2M
$630.8M
Q2 24
$324.9M
$581.9M
Total Assets
CLOV
CLOV
PRG
PRG
Q1 26
$2.0B
Q4 25
$541.0M
$1.6B
Q3 25
$559.7M
$1.5B
Q2 25
$575.0M
$1.5B
Q1 25
$583.7M
$1.5B
Q4 24
$580.7M
$1.5B
Q3 24
$653.0M
$1.4B
Q2 24
$674.2M
$1.5B
Debt / Equity
CLOV
CLOV
PRG
PRG
Q1 26
Q4 25
0.80×
Q3 25
Q2 25
Q1 25
Q4 24
0.99×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
PRG
PRG
Operating Cash FlowLast quarter
$-66.9M
Free Cash FlowOCF − Capex
$-69.0M
FCF MarginFCF / Revenue
-14.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
PRG
PRG
Q1 26
Q4 25
$-66.9M
$-54.9M
Q3 25
$12.1M
$110.0M
Q2 25
$5.4M
$69.9M
Q1 25
$-16.3M
$209.9M
Q4 24
$34.8M
$-84.5M
Q3 24
$50.0M
$31.9M
Q2 24
$44.8M
$55.4M
Free Cash Flow
CLOV
CLOV
PRG
PRG
Q1 26
Q4 25
$-69.0M
$-57.5M
Q3 25
$11.4M
$106.5M
Q2 25
$4.8M
$68.0M
Q1 25
$-16.5M
$208.0M
Q4 24
$33.3M
$-86.8M
Q3 24
$49.6M
$29.8M
Q2 24
$44.4M
$53.5M
FCF Margin
CLOV
CLOV
PRG
PRG
Q1 26
Q4 25
-14.1%
-10.9%
Q3 25
2.3%
17.9%
Q2 25
1.0%
11.2%
Q1 25
-3.6%
30.4%
Q4 24
9.9%
-15.5%
Q3 24
15.0%
4.9%
Q2 24
12.5%
9.0%
Capex Intensity
CLOV
CLOV
PRG
PRG
Q1 26
Q4 25
0.4%
0.5%
Q3 25
0.1%
0.6%
Q2 25
0.1%
0.3%
Q1 25
0.0%
0.3%
Q4 24
0.5%
0.4%
Q3 24
0.1%
0.3%
Q2 24
0.1%
0.3%
Cash Conversion
CLOV
CLOV
PRG
PRG
Q1 26
Q4 25
-1.36×
Q3 25
3.32×
Q2 25
1.82×
Q1 25
6.05×
Q4 24
-1.47×
Q3 24
0.38×
Q2 24
6.04×
1.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons